Amphastar Pharmaceuticals Reports Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2015

Go back to Amphastar Pharmaceuticals Reports Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2015

Amphastar Pharma (AMPH) Tops Q4 EPS by 23c

March 14, 2016 4:21 PM EDT

Amphastar Pharma (NASDAQ: AMPH) reported Q4 EPS of $0.19, $0.23 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $76.9 million versus the consensus estimate of $64.48 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

... More